
|Articles|January 29, 2016
Hep C, Melanoma Drug Approvals Highlight Week in Specialty Pharmacy
Author(s)Davy James, Managing Editor
Top stories of the week on Specialty Pharmacy Times.
Advertisement
[<a href="//storify.com/pharmacytimes/hep-c-melanoma-drug-approvals-highlight-week-in-sp" target="_blank">View the story "Hep C, Melanoma Drug Approvals Highlight Week in Specialty Pharmacy" on Storify</a>]
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Poherdy, First Biosimilar to Perjeta, For HER2 Breast Cancer Indications
2
Ziftomenib Receives FDA Approval for Acute Myeloid Leukemia With NPM1 Mutations
3
Study Finds Similar Outcomes Between hMPV and RSV Hospitalizations
4
Higher Ultra-Processed Food Intake Linked to Increased Prediabetes Risk in Young Adults
5






















































































































































































































